FDA Investigator Joseph A Morkunas

Joseph A Morkunas has inspections in 3 countries as of 05 Sep 2023. Joseph A Morkunas has collaborated with a combinined 3476 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
85
Last Inspection Date:
05 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100006379
Country:
United States of America, Israel, Germany
Co-Investigator(s):
A Williams, Adam True, Alan M Barker, Alicia M Mozzachio, Amanda Dinaro, Amanda S Zorn, Ana E Morales, Ana L Kewes, Andrew A Leboeuf, Andrew J Barrowcliff, Anna Flynn, Anthony R Ronga, Ashley L Reiber, Audrey Dela Cruz, Bradley J Maunder, Brentley S Collins, Brian D Nicholas, Brian D Nicholson, Brian P Emanuel, Brittani N Franklin, Bruce H Mccullough, Bryan L Mcguckin, Carl A Huffman, III, Carrie Ann Plucinski, Catherine J Laufmann, Chad E Schmear, Chad J Whitwell, Chad W Rice, Charles M Kerns, BLT DO, Chiang Syin, PhD, Christina A Miller, Christopher B Harding, Christopher D Leach, Clotia Cabbey Mensah, Cynthia A Harris, MD, RN, Daniel C Kearns, Daniel Kearns, Daniel T Lee, Dariusz Galezowski, David J Gallant, David J Gasparovich, David Perkins, Debra Boyd Seale, Debra I Love, Debra L Boyd Seale, Denise R Beuttenmuller, Dr. Guang Gao, PhD, Elliot P Cowam, PhD, Emma R Schaefer, Eric M Mueller, PharmD, Eric S Pittman, Erin L Mcfiren, Freed A Sharif, Gene D Arcy, Harperd, Helen B Ricalde, Howard Sklamberg, Humera Khan, Humera T Khan, Jacob M Dyer, James E Roberts, James M Simpson, James P Duggan, James T Karpus, James W Leonette, James W Plucinski, Jan B Welch, Jan Welch, Janae D Price, Janete F Guardia, Jason A Morrunas, Jason F Chancey, Jeanne J Chiu, Jeanne M Morris, Jennifer A D'angelo, Jeremy W Rotton, Jerri E Lothrop, Jesse A Vazquez, Jesse Vazquez, Jessica L Burley, Joan A Loreng, John M Gusto, John M Seale, Joseph A Morkanus, Joseph A Norkunas, Joseph A Piechocki, Joseph D Cooper, Joshua M Adams, Jude C Dikes, Julie D Bringger, Karen E Masley, Karen Emasley Joseph, Karen Emaslwey Joseph, Kathleen B Swat, Kathleen S Tormey, Kenneth Nieves, Kevin T Gerrity, Kimberly Lewandowski Walker, Krista N Flores, Kristin D Jarrell, Kujtim Sadiku, Lagurta M Mayher, Lakisha M Williams, Larry F Hallberg, Lauren A Crivellone, Laurie A Haxel, Laurimer Kuilan Torres, Leeterry Moore, Lequita M Mayhew, Leslie D Hintz, Lindsey L Kirsh, Lisa Hayka, Lisa Hornback, Lorelei S Jarrell, Lori S Lawless, Marc S Neubauer, Marcia A Worley, Marcus A Ray, Margare Torres Vazquez, Margaret Mtorres Vazquez, Margaret Torres Vazquez, Maria Diaz, Mark E Frank, Mark G Peterson, Mark I Kaspar, Martha T Olone, Matthew J Sienko, Matthew R Buenconsejo, Maureen C Melvin, Merideth K Rose, Michael D Robinson, Michele L Glendenning, Natasha R Johnson, Nibin Varghese, MS, Nicholas F Lyons, Nicholas J Presto, Nicholas P Diorio, Nicholas Z Lu, Nicole J Clausen, Nicole K Trudel, Nicole S Williams, Norman L Brown, Norman Wong, Omotunde O Osunsanmi, Pablo Alcantara, Paola S Barnett, Patricia A Mcilroy, Patrick E Gainer, Paula P Demichael, Phung Thien Nguyen, Prabhu P Raju, Pradip N Akolkar, Rachel T Evans, Rafael Padilla, Raul Alicea, Rebecca Rodriguez, Richard Jay Tucker, RS, Robert K Linn, Robert L Stevenson, Roberta W Cunningham, Rochelle K Kimmel, Rodney D Combs, Ronald T Nowalk, Rosemary A Sexton, Rosemary A Wood, Russell K Riley, Ryan S Martin, Samuel W Labinjo, Sarah B Tanksley, Sean P Ryan, Sergio Chavez (NMI), Shafiq S Ahadi, State Agency, Stefen D Mcmillan, Stephen C Mahoney, Stephen D Eich, Steven E Kane, Sullan, Susan A Zullo, PhD, Susan D Yuscius, Susan M Jackson, Susan P Bruederle, Susan W Ciani, Tamara Brey, Tania E Vizcaino, That Q Dang, Thomas J Arista, Todd M Stankewicz, Todd Q Dang, Uraku Obasi, Uruaku A Obasi, Vioela J Caze, Wanda B Coats, William D Sherman, William G Nelson, William R Weissinger, Yvonne E Lozano, Yvonne Lozano, Zerita White

Joseph A Morkunas's Documents

Publish Date Document Type Title
November, 2011 EIR Abbott Laboratories - EIR, 2011-11-08
August, 2013 FDA 483 Tetracore, Inc. - Form 483, 2013-08-14
June, 2011 FDA 483 ESB Enterprises L.L.C. - Form 483, 2011-06-06
March, 2013 FDA 483 Medifix, Inc. - Form 483, 2013-03-18
March, 2009 FDA 483 Sterigenics U.S., LLC - Form 483, 2009-03-18
April, 2009 FDA 483 Siemens Medical Solutions USA, Inc. - Form 483, 2009-04-27
April, 2009 EIR Nutripack LLC - EIR, 2009-04-15
October, 2010 FDA 483 Gendex Dental Systems - Form 483, 2010-10-08
December, 2010 FDA 483 Ciba Vision Corporation - Form 483, 2010-12-22
May, 2012 FDA 483 Medefil, Inc. - Form 483, 2012-05-25
May, 2012 EIR Medefil, Inc. - EIR, 2012-05-25
October, 2008 FDA 483 Tricor Systems - Form 483, 2008-10-09
October, 2012 FDA 483 Rauland-Borg Corp - Form 483, 2012-10-25
December, 2012 FDA 483 Del Medical, Inc. - Form 483, 2012-12-17
November, 2010 FDA 483 Rauland-Borg Corp - Form 483, 2010-11-29
September, 2012 FDA 483 Richard Wolf Medical Instruments Corp. - Form 483, 2012-09-10
March, 2012 FDA 483 Midmark Corp dba Progeny Inc - Form 483, 2012-03-13
June, 2011 FDA 483 Natus Medical Inc - Form 483, 2011-06-30
September, 2013 FDA 483 Terumo Medical Corporation - Form 483, 2013-09-12
July, 2012 FDA 483 Abbott Molecular, Inc. - Form 483, 2012-07-11
March, 2011 FDA 483 Baxter Healthcare Corp - Form 483, 2011-03-10
September, 2010 FDA 483 Haemoscope Division of Haemonetics Corp - Form 483, 2010-09-09
July, 2012 EIR Abbott Molecular, Inc. - EIR, 2012-07-11
September, 2012 FDA 483 Medgyn Products, Inc. - Form 483, 2012-09-06
August, 2010 EIR Abbott Laboratories - EIR, 2010-08-12
December, 2008 EIR Abbott Laboratories - EIR, 2008-12-11
February, 2013 FDA 483 Endoplus - Form 483, 2013-02-26
November, 2011 FDA 483 Chek Lab, Inc. - Form 483, 2011-11-22

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more